The burden of sepsis in critically ill human immunodeficiency virus-infected patients-a brief review

Brazilian Journal of Infectious Diseases

Volumn 19, Issue 1, 2015, Pages 77-81

  Moreira, José ^a  

^a Funda??o Oswaldo Cruz   (Brazil)

Author keywords

Highly active antiretroviral therapy; Human immunodeficiency virus; Intensive care; Sepsis

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFICACY; HEALTH CARE QUALITY; HEALTH IMPACT ASSESSMENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION SENSITIVITY; INFLAMMATION; INTENSIVE CARE UNIT; OPPORTUNISTIC INFECTION; PRACTICE GUIDELINE; PROGNOSIS; SEPSIS; SHORT SURVEY; TREATMENT INDICATION; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CRITICAL ILLNESS; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; MORTALITY;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; CRITICAL ILLNESS; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; PROGNOSIS; SEPSIS;

EID: 84921783323     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/j.bjid.2014.05.010     Document Type: Short Survey

References (39)

1. Antiretroviral Therapy Cohort Collaboration Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet 2008, 372:293-299.
2. van Sighem A.I., Gras L.A., Reiss P., et al. ATHENA national observational cohort study: life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals. AIDS 2010, 24:1527-1535.
3. Vargas-Infante Y.A., Guerrero M.L., Ruiz-Palacios G.M., et al. Improving outcome of human immunodeficiency virus-infected patients in a Mexican intensive care unit. Arch Med Res 2007, 38:827-833.
4. Khouli H., Afrasiabi A., Shibli M., et al. Outcome of critically ill human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. J Intensive Care Med 2005, 20:327-333.
5. Morris A., Creasman J., Turner J., Luce J.M., Wachter R.M., Huang L. Intensive care of human immunodeficiency virus-infected patients during the era of highly active antiretroviral therapy. Am J Respir Crit Care Med 2002, 166:262-267.
6. Narasimhan M., Posner A.J., DePalo V.A., Mayo P.H., Rosen M.J. Intensive care in patients with HIV infection in the era of highly active antiretroviral therapy. Chest 2004, 125:1800-1804.
7. Nickas G., Wachter R.M. Outcomes of intensive care for patients with human immunodeficiency virus infection. Arch Intern Med 2000, 160:541-547.
8. Powell K., Davis J.L., Morris A.M., et al. Survival for patients with HIV admitted to the ICU continues to improve in the current era of combination antiretroviral therapy. Chest 2009, 135:11-17.
9. Barbier F., Coquet I., Legriel S., et al. Etiologies and outcome of acute respiratory failure in HIV-infected patients. Intensive Care Med 2009, 35:1678-1686.
10. Casalino E., Wolff M., Ravaud P., et al. Impact of HAART advent on admission patterns and survival in HIV-infected patients admitted to an intensive care unit. AIDS 2004, 18:1429-1433.
11. Chiang H.H., Hung C.C., Lee C.M., et al. Admissions to intensive care unit of HIV-infected patients in the era of highly active antiretroviral therapy: etiology and prognostic factors. Crit Care 2011, 15:R202.
12. Mrus J.M., Braun L., Yi M.S., Linde-Zwirble W.T., Johnston J.A. Impact of HIV/AIDS on care and outcomes of severe sepsis. Crit Care 2005, 9:R623-R630.
13. Noursadeghi M., Katz D., Miller R. HIV-1 infection of mononuclear phagocytic cells: the case for bacterial innate immune deficiency in AIDS. Lancet Infect Dis 2006, 6:794-804.
14. Collini P., Noursadeghi M., Sabroe I., Miller R.F., Dockrell D.H. Monocyte and macrophage dysfunction as a cause of HIV-1 induced dysfunction of innate immunity. Curr Mol Med 2010, 10:727-740.
15. Croda J., Croda M., Neves A., De Sousa dos Santos S. Benefit of antiretroviral therapy on survival of human immunodeficiency virus-infected patients admitted to an intensive care unit. Crit Care Med 2009, 37(5):1605-1611.
16. Silva J.M., De Sousa dos Santos S. Sepsis in AIDS patients: clinical, etiological and inflammatory characteristics. J Int AIDS Soc 2013, 16:17344.
17. Greenberg J., Lennox J., Martin G. Outcomes for critically ill patients with HIV and severe sepsis in the era of highly active antiretroviral therapy. J Crit Care 2012, 27:51-57.
18. Japiassú A.M., Amâncio R.T., Mesquita E.C., et al. Sepsis is a major determinant of outcome in critically ill HIV/AIDS patients. Crit Care 2010, 14:R152.
19. Haddy R.I., Richmond B.W., Trapse F.M., Fannin K.Z., Ramirez J.A. Septicemia in patients with AIDS admitted to a university health system: a case series of eighty-three patients. J Am Board Fam Med 2012, 25:318-322.
20. Cobos-Trigueros N., Rinaudo M., Solé M., et al. Acquisition of resistant microorganisms and infections in HIV-infected patients admitted to the ICU. Eur J Clin Microbiol Infect Dis 2013, 10.1007/s10096-013-1995-5.
21. Gea-Banacloche J.C., Opal S.M., Jorgensen J., Carcillo J.A., Sepkowitz K.A., Cordonnier C. Sepsis associated with immunosuppressive medications: an evidence-based review. Crit Care Med 2004, 32(11 Suppl.):S578-S590.
22. Amancio R.T., Japiassu A.M., Gomes R.N., et al. The innate immune response in HIV/AIDS septic shock patients: a comparative study. PLOS ONE 2013, 8:e68730.
23. Akgun K.M., Tate J.P., Pisani M., et al. Medical ICU admission diagnoses and outcomes in human immunodeficiency virus-infected and virus-uninfected veterans in the combination antiretroviral era. Crit Care Med 2013, 41:1458-1467.
24. Amancio F.F., Lambertucci J.R., Cota G.F., Antunes C.M. Predictors of the short- and long-term survival of HIV-infected patients admitted to a Brazilian intensive care unit. Int J STD AIDS 2012, 23:692-697.
25. Coquet I., Pavie J., Palmer P., et al. Survival trends in critcally ill HIV-infected patients in the highly active antiretroviral therapy era. Crit Care. 2010, 14:R107.
26. Lederman M.M., Funderburg N.T., Sekaly R.P., Klatt N.R., Hunt P.W. Residual immune dysregulation syndrome in treated HIV infection. Adv Immunol 2013, 119:51-83.
27. Adlakha A., Pavlou M., Walker D.A., et al. Survival of HIV-infected patients admitted to the intensive care unit in the era of highly active antiretroviral therapy. Int J STD AIDS 2011, 22:498-504.
28. van Lelyveld S.F., Wind C.M., Mudrikova T., et al. Short- and long-term outcome of HIV-infected patients admitted to the intensive care unit. Eur J Clin Microbiol Infect Dis 2011, 30:1085-1093.
29. Rivers E., Nguyen B., Havstad S., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345:1368-1377.
30. Guérin C., Reignier J., Richard J.C., et al. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 2013, 368:2159-2168.
31. Acute Respiratory Distress Network Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000, 342:1301-1308.
32. van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001, 345:1359-1367.
33. Huang L., Quartin A., Jones D., Havlir D. Intensive care of patients with HIV infection. N Engl J Med 2006, 355:173-181.
34. Morquin D., Le Moing V., Mura T., et al. Short- and long-term outcomes of HIV-infected patients admitted to the intensive care unit: impact of antiretroviral therapy and immunovirological status. Ann Intensive Care 2012, 2:25.
35. Morris A., Wachter R., Luce J., Turner J., Huang L. Improved survival with highly active antiretroviral therapy in HIV-infected patients with severe Pneumocystis carinii pneumonia. AIDS 2003, 17:73-80.
36. Meybeck A., Lecomte L., Valette M., et al. Should highly active antiretroviral therapy be prescribed in critically ill HIV-infected patients during the ICU stay? A retrospective cohort study. AIDS Res Ther 2012, 9:27.
37. Zolopa A.R., Andersen J., Komarow L., et al. Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLOS ONE 2009, 4:e5575.
38. Lanoix J.P., Andrejak C., Schmit J.L. Antiretroviral therapy in intensive care. Med Mal Infect 2011, 41:353-358.
39. Dellinger R.P., Levy M.M., Rhodes A., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013, 41:580-637.